-
Registrations and welcome coffeeJan. 29
-
S3 - Nursing 1: Sex-Specific Cardiovascular Risk Modifiers - Pregnancy, Menopause, and Aging
Jan. 29
-
S1 - YCC - Invisible Killers: Pollution, Noise & Climate Stress on the Heart?
Jan. 29
-
S2 - Radiation
Jan. 29
-
S5 - Nursing - 2 - Inside the Rhythm: Devices, Leads, and Daily Living
Jan. 29
-
S4 - Keynote & Gold medal - Improving Cardiovascular Health In The EU: The Challenges Ahead
Jan. 29
-
Coffee break & best Poster
Jan. 29
-
S8 - Nursing - 3 - Circulatory Challenges: Managing Pressure, Clotting, and Cerebral Events
Jan. 29
-
S6 - BACTS & BSC Joint session - The tricuspid valve: how to manage it right?
Jan. 29
-
S7 - Scientific symposium sponsored by AstraZeneca: Belgian Initiatives in Cardiovascular Care to improve the journey of patients with heart failure, hypertension, and cardiac amyloidosis
Jan. 29
Evandro de Azambuja, MD, PhD, is the Head of the Medical Support Team (Academic Promoting Team) located at the Institut Jules Bordet, HUB, Université Libre de Bruxelles in Brussels, Belgium
Dr. de Azambuja earned his first PhD from the Federal University of Rio Grande do Sul, Porto Alegre, Brazil, in May 2007 and his second PhD from the Université Libre de Bruxelles (U.L.B) in December 2015.
Dr. de Azambuja is a member of different societies including ESMO, ASCO and BSMO. He also has been chairing different ESMO activities such as Fellowship Committee (2018-2022), ESMO Leaders Generation Program (2018-2022). He is the current ESMO membership director 2023-2025 and BSMO (Belgian Society for Medical Oncology) President 2023-2026
He has (co)-authored about 370 peer-reviewed articles and 15 book chapters. He has been a member of Education and Scientific Committees of the ESMO, ESMO Breast, EBCC and ECCO meetings and invited international speaker in different conferences and countries.

Liesbeth Rosseel is an interventional cardiologist at the newly merged AZORG Hospital in Aalst, Belgium. She trained in coronary interventions at ZNA Middelheim (Belgium) and structural heart interventions at Rigshospitalet (Copenhagen, Denmark). After serving as a Consultant Cardiologist at Galway University Hospital (Ireland), she returned to Belgium in 2021. She completed her PhD in 2024 on “Lean TAVI” and specializes in structural interventions, including LAAC, PFO/ASD closure, and emerging percutaneous valve therapies.

Wouter C. Meijers MD PhD FESC FHFA
Cardiologist, (Advanced) Heart Failure & Cardio-Oncology
